• Cell · Sep 2021

    COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.

    • Muge Cevik, Nathan D Grubaugh, Akiko Iwasaki, and Peter Openshaw.
    • Division of Infection and Global Health, School of Medicine, University of St Andrews, Fife, UK. Electronic address: mc349@st-andrews.ac.uk.
    • Cell. 2021 Sep 30; 184 (20): 5077-5081.

    AbstractAs the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.Copyright © 2021 Elsevier Inc. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.